PAWC
P.A.W. Capital Portfolio holdings
AUM
$51.9M
1-Year Return
46.14%
This Quarter Return
-11.17%
1 Year Return
+46.14%
3 Year Return
+74.13%
5 Year Return
+167.35%
10 Year Return
+839.74%
AUM
$86.7M
AUM Growth
-$10.7M
(-11%)
Cap. Flow
+$2.85M
Cap. Flow
% of AUM
3.29%
Top 10 Holdings %
Top 10 Hldgs %
36.47%
Holding
70
New
4
Increased
21
Reduced
12
Closed
8
Top Buys
| 1 |
Euronet Worldwide
EEFT
|
$1.7M |
| 2 |
Allot
ALLT
|
$1.47M |
| 3 |
Ares Capital
ARCC
|
$1.3M |
| 4 |
Akebia Therapeutics
AKBA
|
$1.26M |
| 5 |
LOCK
LifeLock, Inc.
LOCK
|
$1.1M |
Top Sells
| 1 |
MM
MILLENNIAL MEDIA INC COM STK (DE)
MM
|
$1.9M |
| 2 |
ORBK
Orbotech Ltd
ORBK
|
$1.66M |
| 3 |
LendingTree
TREE
|
$930K |
| 4 |
Enphase Energy
ENPH
|
$913K |
| 5 |
WEB
Web.com Group, Inc.
WEB
|
$843K |
Sector Composition
| 1 | Technology | 37.54% |
| 2 | Healthcare | 16.65% |
| 3 | Communication Services | 9.74% |
| 4 | Financials | 8.72% |
| 5 | Energy | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Ares Capital
ARCC
$15.8B
| $1.3M | 1.49% |
+90,000
| New | +$1.3M |
|
|
MNDT
27
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.27M | 1.46% |
40,000
+7,500
| +23% | +$239K |
|
|
28
Akebia Therapeutics
AKBA
$806M
| $1.26M | 1.44% |
+130,000
| New | +$1.26M |
|
|
ESRX
29
DELISTED
Express Scripts Holding Company
ESRX
| $1.21M | 1.39% |
15,000
| – | – |
|
|
FWM
30
DELISTED
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
| $1.2M | 1.38% |
1,145,000
+60,000
| +6% | +$63K |
|
31
HCA Healthcare
HCA
$96.7B
| $1.16M | 1.33% |
15,000
-3,000
| -17% | -$232K |
|
32
Iovance Biotherapeutics
IOVA
$792M
| $1.15M | 1.32% |
200,000
+120,000
| +150% | +$691K |
|
33
Aviat Networks
AVNW
$286M
| $1.14M | 1.31% |
183,333
-31,834
| -15% | -$199K |
|
|
BBBY
34
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.14M | 1.31% |
20,000
+5,000
| +33% | +$285K |
|
|
PLPM
35
DELISTED
Planet Payment, Inc
PLPM
| $1.13M | 1.3% |
400,000
| – | – |
|
|
SHOR
36
DELISTED
ShoreTel, Inc.
SHOR
| $1.12M | 1.29% |
150,000
| – | – |
|
37
Gilead Sciences
GILD
$140B
| $1.08M | 1.24% |
11,000
+2,500
| +29% | +$245K |
|
|
EXAR
38
DELISTED
Exar Corporation
EXAR
| $952K | 1.09% |
160,000
+10,000
| +7% | +$59.5K |
|
39
Amgen
AMGN
$151B
| $830K | 0.95% |
6,000
| – | – |
|
40
GE Aerospace
GE
$298B
| $706K | 0.81% |
5,843
| – | – |
|
41
AT&T
T
$211B
| $684K | 0.78% |
27,804
| – | – |
|
42
Philip Morris
PM
$249B
| $666K | 0.76% |
8,400
| – | – |
|
|
LKM
43
DELISTED
Link Motion Inc.
LKM
| $662K | 0.76% |
200,000
| – | – |
|
44
PepsiCo
PEP
$201B
| $660K | 0.76% |
7,000
| – | – |
|
45
Johnson & Johnson
JNJ
$428B
| $653K | 0.75% |
7,000
| – | – |
|
46
Altria Group
MO
$112B
| $653K | 0.75% |
12,000
-3,000
| -20% | -$163K |
|
47
Verizon
VZ
$186B
| $653K | 0.75% |
15,000
| – | – |
|
48
DuPont de Nemours
DD
$32.1B
| $636K | 0.73% |
7,435
| – | – |
|
49
Pfizer
PFE
$140B
| $628K | 0.72% |
21,080
| – | – |
|
50
Coca-Cola
KO
$294B
| $602K | 0.69% |
15,000
| – | – |
|